Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

10 Jul 2008 07:00

RNS Number : 7381Y
Craneware plc
10 July 2008
 



Craneware plc

("Craneware" or the "Company")

TRADING UPDATE 

10 July 2008 - Craneware plc, (AIM: CRW) a leader in revenue cycle management software solutions for the US healthcare market, is pleased to give an update today on trading during the year to 30 June 2008. 

The Company has performed strongly during the year, exceeding targets set at the time of the IPO in September, culminating in the signing of the two separate agreements with Catholic Healthcare West and Catholic Health East announced within the last month, revenues from which will only be recognised in subsequent years. 

During the year, the management continued to execute on its stated strategy of broadening the Company's customer base signing up 194 new hospitals during the year, resulting in Craneware's software being used in 950 US hospitals up from 801 at the beginning of the year. Renewal rates for multi-year contracts remain above 90%.

In additional to broadening the customer base, the Company also increased customer penetration through the cross-sale of two additional products, Patient Charge Estimator™ and Pharmacy ChargeLink™, which were launched at the end of the 1st half of the year. Over 30% of new hospital wins during the year included at least one of the newly launched products with additional sales made to existing hospital clients ahead of management's expectations. 

The Board is therefore confident of reporting results for the year ended 30 June 2008 in line with expectations. These results will be announced on Tuesday 9 September 2008. 

Keith Neilson, CEO of Craneware, commented, "We are delighted with the strong growth achieved in the year, underlining our position as the leader in revenue cycle management software in the US. We have exceeded our goals as stated at the time of the Company's IPO in September last year, and are confident in our ability to continue to execute upon our strategy in the year ahead." 

For further information, please contact:

Craneware plc

KBC Peel Hunt

ICIS

+44 (0)1506 407 666

+44 (0)20 7418 8900

+44 (0)20 7651 8688

Keith Neilson, CEO

Oliver Scott

Tom Moriarty

Sandy McDougall, CFO

Deon Veldtman

Caroline Evans-Jones

About Craneware

Founded in 1999, Craneware has headquarters in LivingstonScotland, with offices in FloridaArizona and Kansas, employing over 100 staff. Craneware's products, which include the Company's flagship, Chargemaster Toolkit® assist US healthcare providers in reducing billing errors, ensuring the timely and accurate submission of claims and managing compliance risk. More information about Craneware plc and its services can be found on-line at the Company's corporate website, www.craneware.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRLMFTMMTMBPP
Date   Source Headline
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSFY23 Trading Update and Notice of Results
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20234:44 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.